JMVNX
Price
$14.58
Change
-$0.25 (-1.69%)
Updated
Jun 13 closing price
Net Assets
1.33B
JVMAX
Price
$26.02
Change
-$0.31 (-1.18%)
Updated
Jun 13 closing price
Net Assets
21.73B
Interact to see
Advertisement

JMVNX vs JVMAX

Header iconJMVNX vs JVMAX Comparison
Open Charts JMVNX vs JVMAXBanner chart's image
JHFunds2 Mid Value NAV
Price$14.58
Change-$0.25 (-1.69%)
VolumeN/A
Net Assets1.33B
JHancock Disciplined Value Mid Cap A
Price$26.02
Change-$0.31 (-1.18%)
VolumeN/A
Net Assets21.73B
JMVNX vs JVMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMVNX vs. JVMAX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a Hold and JVMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 21.7B vs. JMVNX (1.33B). JMVNX pays higher dividends than JVMAX: JMVNX (1.30) vs JVMAX (0.60). JMVNX was incepted earlier than JVMAX: JMVNX (16 years) vs JVMAX (28 years). JVMAX (1.13) is less costly to investors than JMVNX (0.96). JVMAX (47.00) and JMVNX (46.00) have comparable annual turnover. JMVNX has a lower initial minimum investment than JVMAX: JMVNX (0) vs JVMAX (1000). JVMAX annual gain was more profitable for investors over the last year : -3.68 vs. JMVNX (-14.75). JVMAX return over 5 years is better than : 48.97 vs. JMVNX (14.74).
JMVNXJVMAXJMVNX / JVMAX
Total Expense Ratio0.951.1285%
Annual Report Gross Expense Ratio0.961.1385%
Fund Existence16 years28 years-
Gain YTD-4.2682.360-181%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B21.7B6%
Annual Yield % from dividends1.300.60218%
Returns for 1 year-14.75-3.68400%
Returns for 3 years-11.4015.06-76%
Returns for 5 years14.7448.9730%
Returns for 10 years-3.1431.57-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
RYI20.78-0.47
-2.21%
RYERSON HOLDING Corp
SWK65.26-2.16
-3.20%
Stanley Black & Decker
NMRA0.84-0.05
-5.94%
Neumora Therapeutics
DWTX4.65-0.53
-10.23%
Dogwood Therapeutics Inc